Literature DB >> 9790427

Clinical observations of unresponsive mucosal leishmaniasis.

P D Marsden1, H A Lessa, M R Oliveira, G A Romero, J G Marotti, R N Sampaio, A Barral, E M Carvalho, C C Cuba, A V Magalhães, V O Macêdo.   

Abstract

We report the long-term clinical follow-up of two patients with unresponsive mucosal leishmaniasis due to Leishmania (Viannia) braziliensis from the Três Braços area in Bahia State, Brazil. Both were agricultural male workers with extensive upper respiratory mucosal involvement that was not cured with conventional and experimental therapy.

Entities:  

Mesh：

Year:  1998        PMID： 9790427     DOI： 10.4269/ajtmh.1998.59.543

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  3 in total

1.  The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.

Authors:  Rajendranath Ramasawmy; Eliane Menezes; Andrea Magalhães; Joyce Oliveira; Léa Castellucci; Roque Almeida; Maria Elisa A Rosa; Luiz Henrique Guimarães; Marcus Lessa; Elza Noronha; Mary E Wilson; Sarra E Jamieson; Jorge Kalil; Jenefer M Blackwell; Edgar M Carvalho; Amélia Ribeiro de Jesus
Journal:  Infect Genet Evol       Date:  2010-04-27       Impact factor: 3.342

2.  A perspective on the emergence of sialic acids as potent determinants affecting leishmania biology.

Authors:  Angana Ghoshal; Chitra Mandal
Journal:  Mol Biol Int       Date:  2011-07-25

3.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Mariona Pinart; José-Ramón Rueda; Gustavo As Romero; Carlos Eduardo Pinzón-Flórez; Karime Osorio-Arango; Ana Nilce Silveira Maia-Elkhoury; Ludovic Reveiz; Vanessa M Elias; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.